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Summary
Rationale:  Epilepsy  is  among  the  most  common  neurological  disorders  worldwide.  However,
there  are  few  large,  population-based  studies  of  the  prevalence  and  risk  factors  for  epilepsy  in
southern  Africa.
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Methods:  From  August  2008  to  February  2009,  as  part  of  a  multi-site  study,  we  undertook  a  three-
stage,  population-based  study,  embedded  within  the  Agincourt  health  and  socio-demographic
surveillance system,  to  estimate  the  prevalence  and  identify  risk  factors  of  active  convulsive
epilepsy (ACE)  in  a  rural  South  African  population.
Results:  The  crude  prevalence  of  ACE,  after  adjusting  for  non-response  and  the  sensitivity  of  the
screening  method,  was  7.0/1,000  individuals  (95%CI  6.4—7.6)  with  signiﬁcant  geographic  hetero-
geneity  across  the  study  area.  Being  male  (OR  =  2.3;  95%CI  1.6—3.2),  family  history  of  seizures
(OR =  4.0;  95%CI  2.0—8.1),  a  sibling  with  seizures  (OR  =  7.0;  95%CI  1.6—31.7),  problems  after  deliv-
ery  (OR  =  5.9;  95%CI  1.2—24.6),  and  history  of  snoring  (OR  =  6.5;  95%CI  4.5—9.5)  were  signiﬁcantly
associated with  ACE.  For  children,  their  mother’s  exposure  to  some  formal  schooling  was  pro-
tective  (OR  =  0.30;  95%CI  0.11—0.84)  after  controlling  for  age  and  sex.  Human  immunodeﬁciency
virus was  not  found  to  be  associated  with  ACE.
Conclusions:  ACE  is  less  frequent  in  this  part  of  rural  South  Africa  than  other  parts  of  sub-Saharan
Africa. Improving  obstetric  services  could  prevent  epilepsy.  The  relationship  between  snoring  and
ACE  requires  further  investigation,  as  does  the  relative  contribution  of  genetic  and  environmental
ased  risk  in  those  with  a  family  history  of  epilepsy.
Case-control;
Risk factors;
Population-based
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Introduction
Epilepsy  is  one  of  the  most  common  neurological  disorders
in the  world,  affecting  about  69  million  people  worldwide,
with 90  percent  living  in  low-  and  middle-income  countries
(LMICs) (Ngugi  et  al.,  2010).  It  contributes  nearly  one  per-
cent to  the  global  burden  of  disease  (Murray  et  al.,  2012),
and 20  percent  of  the  global  burden  of  epilepsy  is  in  Africa
(World Health  Organization,  2004).
While  these  ﬁgures  suggest  a  large  burden  of  epilepsy  in
Africa, they  are  derived  from  a  limited  number  of  studies
that employ  different  case  deﬁnitions  and  methodologies.
Studies suggest  that  utilizing  hospital  records  in  LMICs
to detect  epilepsy  under-estimates  the  prevalence  by  at
least 80  percent  due  to  limited  health  care  utilization  by
people with  epilepsy  (PWE)  in  these  settings  (Osuntokun
et al.,  1987).  Thus,  population-based  surveys  are  frequently
used to  estimate  prevalence,  though  not  without  limita-
tions, including  the  absence  of  well-demarcated  populations
and vital  statistics  registries.  This  limitation,  coupled  with
the lack  of  trained  medical  personnel  available  to  make
the diagnosis  of  epilepsy,  makes  estimating  the  burden  of
epilepsy in  sub-Saharan  Africa  unusually  challenging.
A  recent  systematic  review  and  meta-analysis  high-
lighted the  signiﬁcant  variation  in  the  prevalence  of  epilepsy
between high-income  countries  and  LMICs,  with  a  higher
prevalence in  LMICs,  especially  in  rural  settings  (Ngugi  et  al.,
2010). The  authors  suggest  that  study  size  and  the  economic
development level  of  the  study  country  largely  explain
the heterogeneity,  although  increases  in  obstetric  injury,
head injuries,  and  infections  and  infestations  of  the  cen-
tral nervous  system  (CNS)  (Newton  &  Garcia,  2012),  such
as toxoplasmosis  and  toxocara  (Wagner  &  Newton,  2009),
malaria (Carter  et  al.,  2004)  and  human  immunodeﬁciency
virus (HIV)  are  thought  to  contribute  (Ngugi  et  al.,  2010),  but
there  is  little  data  from  South  Africa  where  the  prevalence
of HIV  is  very  high.
As part  of  a  multi-centre  study  on  the  epidemiology  of
epilepsy in  demographic  sites  (SEEDS)  (Ngugi  et  al.,  2013),
we conducted  a  three-stage,  population-based  survey  and  a
case-control study  to  determine  the  prevalence  of  and  risk
factors for  active  convulsive  epilepsy  (ACE)  in  rural  South
H
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berved.
frica.  In  particular,  we  were  interested  in  examining  the
isk factors  for  ACE  in  a non-malaria  endemic  area,  particu-
arly HIV  since  it  has  a  high  prevalence  in  South  Africa.
ethodology
opulation  and  study  area
he  study  was  conducted  in  the  rural  Agincourt  health
ub-district, in  which  the  Agincourt  health  and  socio-
emographic surveillance  system  (HDSS)  operates  and  is
ocated 500  kilometers  northeast  of  Johannesburg  (Fig.  1).
he Agincourt  HDSS  was  established  in  1992  as  a research
latform to  inform  health  and  development  policy  through
vidence-based research  (Kahn  et  al.,  2012).  The  pop-
lation has  been  enumerated  through  an  annual  census
pdate, following  baseline  measurement  in  1992  and  cap-
ures vital  statistics  including  births,  deaths,  and  in-  and
ut-migrations.
In 2008,  the  population  was  83,121  individuals  in  15,841
ouseholds and  25  villages  on  420  km2 of  semi-arid  scrub-
and. The  site  forms  part  of  a  former  bantustan,  or  ethnic
homeland’ implemented  during  the  Apartheid  era.  The  pop-
lation is  mainly  Xi-Tsonga  speaking,  with  one-third  (32.8%)
riginally from  Mozambique.
The leading  causes  of  death  ascertained  through  the
gincourt HDSS  are  HIV/AIDS,  cardiovascular  disease  and
rauma (road  trafﬁc  accidents,  assaults)  (Tollman  et  al.,
008). Six  government  clinics,  one  larger  government  health
entre, and  one  public-private  community  health  centre,
ith its  main  focus  being  HIV  and  tuberculosis,  provide  pri-
ary  health  care  services  for  the  population.  Referrals  are
o three  government  district  hospitals  located  25  to  55  km
rom the  sub-district.uman Research  Ethics  Committee  of  the  University  of  the
itwatersrand, Johannesburg,  South  Africa  (Clearance  num-
er: M080455)  and  the  Mpumalanga  Province  Department  of
784  R.G.  Wagner  et  al.
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Cigure  1  Map  of  South  Africa,  Bushbuckridge  Municipality,  
urveillance system,  2008.
ealth’s  Research  and  Ethics  committee.  Written  informed
onsent was  sought  from  each  participant  in  the  study.
arental or  guardian  informed  consent  was  sought  in  the
ase of  children  or  patients  with  cognitive  impairment,  with
erbal assent  being  sought  from  children  and  cognitively
mpaired patients.
ase  deﬁnition  of  active  convulsive  epilepsy  (ACE)
e  identiﬁed  patients  with  Active  convulsive  epilepsy  (ACE)
ince convulsive  epilepsies  are  associated  with  increased
orbidity, mortality  (Diop  et  al.,  2005)  and  greater
ocial stigma  than  non-convulsive  epilepsies  (World  Health
rganization, 2005).  ACE  was  deﬁned  as  having  two  or
ore unprovoked  convulsive  seizures  occurring  more  than
4 hours  apart,  with  at  least  one  seizure  occurring  in  the
2 months  preceding  the  study  or  currently  taking  anti-
pileptic drugs  (AEDs)  (Edwards  et  al.,  2008).
rocedures
etween  August  and  November  2008,  two  questions  (‘Do  you
ave ﬁts  or  has  someone  ever  told  you  that  you  have  ﬁts?’
nd ‘Do  you  experience  episodes  in  which  you  legs  or  arms
ave jerking  movements  or  fall  to  the  ground  and  lose  con-
ciousness?’), used  previously  in  a  similar  study  (Edwards
t al.,  2008),  were  administered  by  census  ﬁeldworkers  to
 senior  member  of  each  household  (n  =  15,841)  on  behalf
f each  member  of  the  household.  The  questions  had  been
iloted previously  in  the  local  language  (Xi-Tsonga)  at  a  dis-
rict hospital  and  had  a  high  speciﬁcity  (100%)  and  sensitivity
98%). The  questions  were  included  in  the  2008  annual  Agin-
ourt  HDSS  census  update  round.  The  two  questions  within
he census  update  constituted  Stage  I  of  the  study  and  sought
o identify  all  people  who  had  experienced  a  seizure  prior
o 1  August  2008  (the  prevalence  day).
In  Stage  II  (August—December  2008),  trained  ﬁeldworkers
isited all  individuals  who  responded  ‘yes’  to  either  of  the
wo questions  in  Stage  I  and  asked  a  detailed  questionnaire,
ased on  previous  studies  (Placencia  et  al.,  1992),  about
he characteristics  and  history  of  the  seizures.  Fieldworkers
ere speciﬁcally  trained  by  the  study  managers  (RGW,  AKN)
n
q
I
2the  Agincourt  sub-district  and  health  and  socio-demographic
nd  study  neurologist  (CRN)  on  the  administration  of  this
uestionnaire. Individuals  who  had  experienced  at  least  two
eizures in  their  lifetime  and  at  least  one  seizure  with  abnor-
al movement  (aimed  at  identifying  convulsive  epilepsy)
n the  preceding  12  months  or  currently  taking  AEDs  were
nvited for  further  assessment  in  the  epilepsy  clinic  within
he following  week  (Stage  III).
In  Stage  III  (September  2008—February  2009),  socio-
emographic information  was  obtained  and  a  specially
rained nurse  made  the  diagnosis  of  ACE,  based  on  a  positive
linical history  provided  by  the  patient’s  caregiver  or  family
ember. A  clinical  examination  was  completed  to  iden-
ify neurological  abnormalities  and  physical  co-morbidities.
lood was  drawn  from  each  patient  for  serological  testing.
 neurologist  (CRN)  conﬁrmed  the  diagnosis  of  epilepsy  by
eviewing all  of  the  patient  records  and  examining  selected
atients.
opulation  sample
n  addition  to  identifying  cases  of  epilepsy  through  the
opulation screen  (Stage  I),  a  random  sample  of  4,500  indi-
iduals (all  ages  and  both  sexes),  from  the  Agincourt  HDSS,
ere screened  with  the  Stage  II  tool.  This  population  sam-
le simulated  the  traditional  two-stage  epilepsy  prevalence
tudy design  (Placencia  et  al.,  1992)  and  was  used  to  eval-
ate the  three-stage  methodology  of  this  study.  Those  who
creened positive  were  referred  for  assessment  in  Stage  III
nd included  as  cases  in  the  case-control  study.
Furthermore,  individuals  who  were  referred  to  the
pilepsy clinic  by  sources  (clinic  staff  and  community
eaders) other  than  the  three-stage  study  were  clinically
ssessed and  those  found  to  have  ACE  were  included  as  cases
n the  case-control  study.
election  of  controls  for  case  control  study
ontrols  were  selected  randomly  from  those  that  screened
egative for  epilepsy  in  the  population  sample  and  fre-
uency matched  to  cases  diagnosed  with  ACE  during  Stage
II of  the  study  (on  age-bands  0—5,  6—12,  13—18,  19—28,
9—49, and  50+  years).  If  the  selected  control  was  not  found
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Table  1  Crude  and  adjusted  prevalence  of  ACE  by  age  and  sex,  Agincourt  sub-district,  South  Africa  2008.
Age  band  Cases  of  ACE  Crude
prevalence
95% Conﬁdence
interval
Adjusted
prevalence
95% Conﬁdence
interval
0  to  5  years  10  0.87  0.33—1.41  2.18  0.88—3.48
6 to  12  years  29  2.23  1.42—3.03  4.79  3.09—6.52
13 to  18  years  34  2.76  1.83—3.68  6.38  4.32—8.42
19 to  28  years  47  2.65  1.89—3.40  6.23  4.47—7.98
29 to  49  years  87  4.70  3.71—5.69  10.95  8.74—13.13
50+ years  38  3.94  2.68—5.19  9.55  6.69—12.41
2.68—3.80  7.43  5.53—7.82
2.20—3.18 6.50 4.53—6.54
variables  on  whether  alcohol  was  consumed  and  period
of consumption  were  analyzed.  Three  additional  variables
were analyzed  for  patients  <18  years  old:  mother’s  mari-
tal status,  whether  the  mother  experienced  some  formal
education, and  her  level  of  education.
Results
Participation  in  the  three-stages  of  the  survey  is  displayed
in Fig.  2.
Table  2  Adjusted  prevalence  of  active  convulsive  epilepsy
by village  of  residence,  Agincourt  sub-district,  2008.
Villagea Cases  of  ACE Adjusted
prevalence
95% Conﬁdence
interval
A  7  7.17 5.36—9.40
B  3  2.77  1.26—5.25
C  20  6.21 4.30—8.67
D  22  10.92 7.78—14.90
E  6  6.31 3.74—9.96
F  11  5.46  3.34—8.42
G  9  7.24  4.22—11.57
H  13  4.67  2.99—6.84
I  1  6.84  4.68—9.65
J  2  5.1  3.27—7.58
K  11  7.39  5.49—9.73
L  3  3.02  1.12—6.21
M  6  3.02  1.21—6.21
N  1  6.77  4.30—10.14
O  6  11.41  7.07—17.38
P  10  8.45  5.53—12.35
Q  7  10.04  7.25—13.55
R  17  14.98  10.06—21.45
S  18  6.64  2.67—13.62
T  11  3.03  0.06—8.83
U  16  9.91  5.67—16.04
V  10  7.2  5.24—9.66
W  4  7.07  4.05—11.46
X  10  9.96  6.17—15.18Male 129  3.24  
Female 116  2.69
after  three  attempted  visits,  another  control  was  selected
randomly as  a  replacement.  For  each  control  selected,  a
clinical history  and  blood  sample  were  taken  and  a  clinical
examination performed.
Serological  testing
Blood  from  cases  and  controls  was  collected  in  Stage  III  of  the
study and  exposure  to  Toxocara  canis  excretory-secretory
antigen with  a  sensitivity  of  97.1%  and  speciﬁcity  of  78.6%
(Noordin et  al.,  2005),  toxoplasmosis  (Toxoplasma  IgG  ELISA
Kit, Genesis  Diagnostics  Ltd,  Product  Code  GD80  (Liesenfeld
et al.,  1996)),  and  Plasmodium  falciparum  IgG  antibodies
tested by  ELISA  was  examined.  Exposure  to  the  larval  stage
(cysticercosis) and  adult  stage  (taeniasis)  of  the  parasite
T. solium  in  the  patients  only,  given  the  absence  of  cys-
ticersosis reported  by  the  local  radiologists.  HIV  antibodies
(Vironostika HIV  Uni-form  II  Ag/Ab  Kit)  were  also  measured
after written  informed  consent  was  received  from  each  indi-
vidual  or  their  legal  guardian.
Statistical  analysis
Data  were  double  entered  into  a  mySQL  database  (Ora-
cleCorp, Redwood  Shores,  CA,  USA).  All  analyses  were
conducted using  Stata  10  (StataCorp,  College  Station,  TX,
USA).
We  adjusted  for  attrition  between  the  stages  of  the  sur-
vey using  a  multiple  imputation  method.  The  ﬁgures  were
also adjusted  for  the  sensitivity  of  the  three-stage  method,
previously calculated  in  a  separate  study  (Ngugi  et  al.,  2012)
(Table 1).  We  report  adjusted  prevalence  by  age,  sex,  and
village of  residence.  We  also  present  prevalence  estimates
standardized to  the  2000  US  population  (US  Census  Bureau,
2000) to  allow  for  global  comparison  and  the  median  and
interquartile range  of  age  of  onset  of  ACE.  Finally,  we  report
the adjusted  prevalence  ﬁgures  from  the  population  sample
of 4,500  individuals.
Factors  associated  with  active  convulsive  epilepsy
In  the  case-control  study,  we  performed  analysis  on  20
socio-demographic and  clinical  variables  and  four  serolog-
ical variables  (Table  3).  We  developed  models  using  logistic
regression and  in  each  model  included  a  variable  of  interest,
adjusted for  age  and  sex.  In  patients  >18  years  of  age,
Y  21  1.77  0.21—6.28
Overall  245  7.01  6.23—7.78
a Villages have been anonymized due to small village size and
conﬁdentiality of individuals with ACE.
786  R.G.  Wagner  et  al.
Stage 1
Stage 2
Stage 3
n=82,818 (99.64%)
Eligible Population (2008 Agincourt Census)     
n=83,121
Deceased; n=45
Not found; n=258
 Screened in Stage 1    
Positive;             
n= 546 (0.66%) Population Sample           
n= 4500Unwilling; n=4
Not found; n=27
Screened in Stage 2     
n= 515 (94.23%) Found; n= 3889 (91.44%)
Positive ;             
n= 354 (68.74%)
Positive ; n= 67 (1.72%)  
(38 also found positive in Stage 1)
Matched Controls        
n= 262 (90.34%)
Unwilling; n=4 Self-referred; found positi ve 
at various Stages Not found; n=27
Assessed in Stage 3     
n= 328 (92.66%)
Assessed in Stage 3      
n= 58 (86.57%) Assessed; n= 262 (100%) Positive (ACE)          
n= 56                   
(33 screen negative in Stage 1)  
Positive (ACE)         Positive (ACE)          
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Figure  2  Study  design  schema  and  n
revalence
e  identiﬁed  245  cases  of  ACE  in  the  three-stage  study.
he unadjusted  prevalence  of  ACE  was  3.0/1,000  individuals
95%CI: 2.6—3.3)  within  the  three-stage  study.  Adjusting  for
ttrition and  the  sensitivity  of  the  three-stage  methodol-
gy (48.6%),  the  adjusted  crude  prevalence  was  7.0/1,000
95%CI: 6.4—7.6).  The  sensitivity  of  48.6%  for  the  three-
tage methodology  was  derived  from  a  validation  study
erformed in  Kenya  using  clinical  assessments  as  the  gold
tandard (Ngugi  et  al.,  2012).  The  prevalence,  standard-
zed to  the  age  distribution  of  the  US  population  in  2000
nd adjusted  for  attrition  and  sensitivity  of  the  three-stage
ethod, was  8.1/1,000  individuals  (95%CI:  7.5—8.7).
Within  the  population  sample  of  3,889  (611  not  found  due
o permanent  out-migration  from  the  study  area)  the  crude
revalence was  6.7/1,000  individuals  (95%CI:  4.1—9.3),
hile the  adjusted  prevalence  (adjusting  for  attrition  and
ensitivity (76.7%)  of  the  two-stage  method  against  the  gold
tandard (Ngugi  et  al.,  2012))  was  9.8/1,000  individuals  (95%
I: 6.9—13.4).
The adjusted  prevalence  of  ACE  by  village  ranged  from
.8—15.0/1,000 individuals  (Table  2)  and  this  variation  was
tatistically signiﬁcant  (p  =  0.05),  although  the  response  rate
or Stage  1  and  Stage  2  did  not  vary  between  villages.
ge  of  onset  of  epilepsy
39  individuals  reported  age  of  onset  of  their  seizures.
he distribution  of  age  of  onset  was  left-skewed  with  7.1%
n =  17)  experiencing  seizures  within  the  ﬁrst  year  of  life
Fig. 3)  and  30.8%  (n  =  74)  before  5  years.  The  median  age
t onset  was  12  years  interquartile  range  was  0—23  years.actors  associated  with  epilepsy
f  the  311  cases  of  ACE  identiﬁed  (245  from  the  three-stage
urvey, 10  additional  cases  from  the  population  sample,  and
t
h
w%)          
n Stage 1)  
ers  of  individuals  at  each  stage,  2008.
6  cases  referred  from  other  sources),  292  cases  (94%)  were
atched to  260  controls.  The  matching  was  not  1:1  due  to
 high  proportion  of  refusals  in  the  controls.
nivariate  analysis
ithin  the  univariate  analysis,  male  sex,  family  history  of
eizures, a  sibling  with  seizures,  problems  after  delivery,  loss
f consciousness  during  head  injury  and  history  of  snoring  at
east three  nights  per  week  were  associated  with  ACE.  ACE
as not  associated  with  exposure  to  any  of  the  parasites
ested and  none  of  the  cases  had  antibodies  to  T.  solium.
For  individuals  >18  years,  neither  alcohol  consumption
or length  of  alcohol  consumption  was  associated  with
CE.
For individuals  <18  years,  having  a  mother  with  some
istory of  formal  education  reduced  her  child’s  risk  of
CE (OR  =  0.34;  95%CI  0.12—0.94),  while  history  of  snor-
ng at  least  three  nights  per  week  (OR  =  6.51;  95%CI
.25—13.06) was  associated  with  an  increased  prevalence
f ACE.  Neither  the  mother’s  level  of  formal  education  nor
other’s marital  status  were  signiﬁcantly  associated  with
CE.
ultivariate  modeling
fter  controlling  for  age  and  sex,  a  family  member  with
eizures, a  sibling  with  seizures,  problems  after  delivery,
nd history  of  snoring  at  least  three  nights  per  week  were
ssociated with  ACE  (Table  3).
Additionally,  for  individuals  <18  years,  a mother  with  for-
al education  (OR  =  0.30;  95%CI  0.11—0.84)  was  found  to  be
rotective.While head  injury  was  not  associated  with  ACE  in  the  mul-
ivariate model,  males  were  twice  as  likely  to  experience
ead injury  (OR  =  2.01;  95%CI  1.06—3.88)  when  compared
ith females.
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Table  3  Multivariate  analysis  of  possible  risk  factors  associated  with  active  convulsive  epilepsy,  Agincourt  sub-district,  2008.
Variable  of  interest  Controls  (n  =  260)  Cases  (n  =  292)  Odds  ratio  (95%  CI)a p-value
Sex
Female  176  (67)  142  (49)  1
Male  85  (33)  150  (51)  2.27  (1.60—3.23)  <0.001
Family  history  of  non-febrile  seizures
Someone  in  family  with  seizures  11  (4)  41  (14)  4.01  (1.99—8.09)  <0.001
Someone  in  family  with  past  history  of  seizure  0  (0)  12  (4) b <0.001
Mother  with  Seizures  0  (0)  3  (1) b 0.146
Father  with  seizures 1  (0)  2  (1)  1.87  (0.16—21.7)  0.615
Sibling  with  seizure 2  (1) 14  (5) 7.05  (1.57—31.68) 0.011
Location  of  birth
Hospital 9  (5) 17  (6) 1
Clinic  109  (62)  144  (54)  0.68  (0.29—1.60)  0.379
Home  57  (32)  97  (36)  0.66  (0.26—1.66)  0.379
Unknown  2  (1)  8  (3)  1.58  (0.267—9.38)  0.612
Adverse  perinatal  events
Normal delivery  163  (96)  246  (93)  1
Abnormal  delivery  7  (4)  19  (7)  2.05  (0.81—5.15)  0.128
No  problems  after  delivery  174  (99)  249  (94)  1
Problems  after  delivery  2  (1)  14  (5)  5.93  (1.18—24.58)  0.030
History  of  febrile  seizures  0  (0)  3  (1) b 0.101
History  of  head  trauma
No history  of  head  injury  245  (94)  260  (89)  1
History  of  head  injury  16  (6)  31  (11)  1.57  (0.82—2.99)  0.170
Loss  of  consciousness  with  the  head  injury 3 (19)  20  (65)  2.69  (0.68—10.61)  0.157
Sociodemographic  and  clinical  characteristics
Abnormal  skull  shape  0  (0)  23  (8) b <0.001
History  of  eating  cassava  154  (59)  190  (66)  1.31  (0.92—1.88)  0.137
History  of  eating  pork 69  (26)  59  (20)  0.70  (0.47—1.04)  0.078
History  of  eating  soil 19  (7) 18  (6)  1.05  (0.53—2.08)  0.878
History  of  dogs  in  dwelling 52  (20)  68  (23)  1.17  (0.77—1.77)  0.457
History  of  cats  in  dwelling 22  (8) 16  (6)  0.64  (0.33—1.27)  0.202
History  of  snoring  (at  least  3x/week) 51  (20) 187  (64) 6.51  (4.45—9.53)  <0.001
Serological  variables
Positive for  malarial  antibodies 71  (33) 78  (39) 1.16  (0.76—1.78)  0.485
Positive  for  HIV  antibodies  49  (23)  36  (18)  0.73  (0.44—1.21)  0.226
Toxocara  77  (36)  73  (37)  1.17  (0.78—1.79)  0.444
Toxoplasmosis  22  (10)  27  (14)  1.20  (0.64—2.25)  0.580
n  (%)
a
ro ex
c
e
(
a
s
F
e
s
t
u
s
fOdd Ratios adjusted for age and sex.
b Indicates that an Odds ratio could not be calculated due to ze
Discussion
From  this  community-based  research  in  rural  northeast
South Africa,  we  found  the  prevalence  of  epilepsy  in  a
rigorous three-stage  study  to  be  lower  than  that  reported
elsewhere in  sub-Saharan  Africa  (SSA).  After  adjusting  for
the sensitivity  of  the  screening  tool  and  attrition  in  the  three
stage survey,  our  ﬁndings  remain  lower  than  the  12.7/1,000
cases of  active  epilepsy  reported  in  a  meta-analysis  of
studies in  rural  areas  of  LMICs  (Ngugi  et  al.,  2010)  and
other SEEDS  sites  in  SSA  (Ngugi  et  al.,  2013).  This  could
be explained  by  differences  in  methodology  or  risk  factors
(Ngugi et  al.,  2013).  ACE  may  only  constitute  25%  of  all
epilepsies (Cockerell  et  al.,  1995;  Edwards  et  al.,  2008).
In high-income  countries,  only  half  of  the  epilepsies  are
i
v
Sposure in the control population.
onvulsive  and  about  half  of  patients  with  convulsive
pilepsy experienced  a  seizure  within  the  last  year
Cockerell et  al.,  1995).  Therefore,  the  real  prevalence  of
ctive epilepsy  may  well  be  higher  than  the  adjusted,  age-
tandardized prevalence  found  in  this  study  (8.1/1,000).
urthermore, the  increased  mortality  associated  with
pilepsy in  Africa  (Diop  et  al.,  2005)  and  the  higher  rates  of
pontaneous remission  (Newton  &  Garcia,  2012)  may  lower
he prevalence  of  active  epilepsy.  We  suspect  the  lower
nadjusted prevalence  ﬁgure  recorded  in  the  three-stage
tudy may  also  be  the  result  of  social  stigma.  A  recent  study
rom Kenya  found  that  false  negative  individuals  in  a  sim-
lar three-stage  study  reported  higher  stigma  scores  on  a
alidated stigma  scale  than  those  positively  identiﬁed  in
tage I  (Ngugi  et  al.,  2012).  While  stigma  levels  are  likely
788  R.G.  Wagner  et  al.
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Wigure  3  Age  of  onset  (bars)  and  prevalence  with  95%  conﬁd
gincourt  sub-district,  2008.
o  vary  depending  on  social  perceptions  of  epilepsy,  further
esearch is  needed  to  deﬁne  the  extent  of  under-reporting.
revalence  by  sex
pilepsy  studies  from  SSA  report  varying  levels  of  prevalence
y sex  (Birbeck  &  Kalichi,  2004).  Our  data  suggest  that  males
re more  likely  to  develop  epilepsy  than  females  during  the
rst two  decades  of  life,  perhaps  due  to  risk  factor  patterns
iscussed below.
ge  of  onset
hese  ﬁndings  from  rural  South  Africa  replicate  those  found
n Tanzania  and  Ethiopia  as  well  as  the  other  SEEDS  sites
Kenya, Tanzania,  Uganda  and  Ghana),  which  suggest  that
he highest  incidence  of  epilepsy  occurs  in  the  ﬁrst  decade  of
ife (Rwiza  et  al.,  2005;  Tekle-Haimanot  et  al.,  1997;  Ngugi
t al.,  2013).  We  found  the  onset  of  epilepsy  to  be  greatest  in
he ﬁrst  year  of  life,  which  is  supported  by  our  case-control
ata in  which  problems  after  delivery  were  associated  with
CE. Underlying  genetic  or  congenital  abnormalities  could
ossibly be  important  causes  of  epilepsy  in  this  community.
he second  peak  of  onset  during  adolescence  (10—15  years)
ay be  indicative  of  environmental,  infectious  and  trau-
atic risk  factors.  The  increased  onset  during  the  fourth
ecade of  life  (30—39  years)  may  reﬂect  the  bimodal  dis-
ribution of  epilepsy  seen  in  high-income  countries  (World
ealth Organization,  2005).  South  Africa  is  experiencing
ncreasing levels  of  cardiovascular  disease  (Mayosi  et  al.,
009), which  may  increase  the  incidence  of  epilepsy  later
n life,  although  this  tends  to  occur  at  younger  age  in  popu-
ations undergoing  epidemiological  transition  than  in  high
ncome populations  (Connor  et  al.,  2007).  Further  research  is
w
C
r
t intervals  (by  5-year  age  bands)  of  active  convulsive  epilepsy,
eeded  to  determine  the  underlying  causes  of  symptomatic
pilepsy in  rural  South  Africa.
revalence  by  village  of  residence
here  are  a  number  of  possible  reasons  for  the  inter-village
eterogeneity of  the  prevalence  of  ACE  across  the  Agin-
ourt sub-district.  While  attrition  of  respondents  between
tages did  not  vary  signiﬁcantly  by  village,  it  is  possible
hat under-reporting  of  convulsions  in  Stage  I (suggested
y 10  false-negatives  in  the  population  sample)  contributed
o the  observed  village-level  heterogeneity.  Differences  in
esponse rates  and  awareness  of  epilepsy  have  been  high-
ighted as  possible  causes  of  heterogeneity  in  small  areas
Edwards et  al.,  2008).
Genetic  abnormalities,  exposure  to  a  particular  environ-
ental risk  factor,  or  access  to  health  facilities  (in  terms
f perinatal  care)  may  also  contribute  to  the  heterogene-
ty, as  we  identiﬁed  several  households  with  more  than  one
erson with  epilepsy.  Ultimately,  however,  it  is  possible  that
he heterogeneity  is  due  to  combination  of  factors  or  may
eﬂect the  actual  distribution  of  epilepsy  in  a  rural  South
frican setting.
actors  associated  with  ACE
he  factors  associated  with  ACE  were  different  in  Agincourt
ompared to  other  SEEDS  sites  (Ngugi  et  al.,  2013).
ex
e  found  a  higher  prevalence  in  males  than  in  females,
hich replicates  other  studies  from  SSA  (Preux  &  Druet-
abanac, 2005).  Being  male  may  put  an  individual  at  greater
isk for  known  risk  factors,  such  as  head  injury.  Within
his study,  males  with  epilepsy  were  twice  as  likely  to
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have  experienced  a  head  injury  than  females  with  epilepsy.
Road trafﬁc  accidents  and  assault—both  common  causes
of traumatic  brain  injury  and  potential  risk  factors  for
epilepsy—were found  to  be  leading  causes  of  death  in
individuals aged  15—49  years  within  the  Agincourt  sub-
district (Tollman  et  al.,  2008).  Furthermore,  it  has  also  been
reported that  females  are  more  likely  to  hide  their  epilepsy
(Preux &  Druet-Cabanac,  2005),  which  may  contribute  to  the
higher prevalence  observed  in  males.
Family history  of  seizures
A family  history  of  seizures  was  shown  to  be  a  signiﬁcant  risk
factor for  developing  convulsive  epilepsy  in  this  study,  as  in
other studies  from  SSA  (Edwards  et  al.,  2008;  Matuja  et  al.,
2001; Nsengiyumva  et  al.,  2003).  Small  numbers  in  our  study
limited exploration  of  relationships  between  family  mem-
bers experiencing  seizures;  however,  this  study  did  ﬁnd  that
having a  sibling  with  seizures  is  a  signiﬁcant  risk  factor  for
epilepsy. Further  research  could  explore  these  relationships
and the  underlying  etiology  to  assess  the  balance  between
genetic, social  and  environmental  exposures.  The  large  and
closely related  family  samples  in  much  of  rural  SSA  could
support expanded  research  into  genetic  risk  factors  for  ACE
(Farnarier &  Genton,  1996).
Adverse perinatal  events
Problems after  delivery  were  found  to  be  a  risk  factor  for
developing epilepsy,  while  problems  during  delivery  do  not
appear  to  be  a  risk  factor.  Studies  from  Tanzania  and  Burundi
found the  risk  of  developing  ACE  to  be  4.5  and  1.9  times
greater, respectively,  after  perinatal  complications  (Matuja
et al.,  2001;  Nsengiyumva  et  al.,  2003).  In  the  current  study,
at least  60%  of  births  occurred  at  clinics  or  hospitals.  In  this
regard, rural  South  Africa  may  differ  from  the  rest  of  SSA
where most  children  are  born  at  home  without  professional
support (Diop  et  al.,  2003).
Snoring
Snoring was  included  to  detect  sleep  disturbance  in  peo-
ple with  epilepsy,  as  documented  elsewhere  (Van  Golde
et al.,  2011).  We  found  that  snoring  was  signiﬁcantly  associ-
ated with  ACE,  though  snoring  was  not  associated  with  body
mass index,  age  or  sex.  Snoring  is  a  symptom  in  obstructive
sleep apnea  (OSA)  (American  Sleep  Disorders  Association,
2001) and  a  number  of  studies  have  found  a  high  prevalence
of sleep  disorders,  including  OSA,  in  people  with  epilepsy
(Beran et  al.,  1999;  Marlow  et  al.,  2000,  2008;  Kader  et  al.,
2010). While  snoring  was  associated  with  ACE  in  this  study,
we cannot  extrapolate  any  temporal  relationship  or  etiolog-
ical association  between  snoring  and  seizures.  Furthermore,
snoring may  be  a  risk  factors  or  a  consequence  of  a  co-
morbid condition,  such  as  sleep  apnea.  Additional  research
is warranted  to  better  understand  this  unusual  ﬁnding.
Mother’s  experience  with  formal  education
In  individuals  <18  years  of  age,  having  a  mother  who
attended some  formal  education  was  found  to  be  a  pro-
tective factor,  which  differs  from  earlier  research  in  LMICs
(Hackett et  al.,  1997;  Mung’ala-Odera  et  al.,  2008).  Edu-
cation is  often  linked  with  higher  socio-economic  status,
which in  turn  can  be  linked  with  better  access  to  healthcare.
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urther  research  to  establish  the  temporality  and  causal
athway of  a  mother’s  education  as  a  protective  factor  for
er child  developing  ACE  is  warranted.
nfections  known  to  be  associated  with  ACE
oxocara,  toxoplasmosis,  HIV  and  malaria  were  not  sig-
iﬁcantly associated  with  ACE  in  this  study,  which  differs
rom other  SEEDS  sites  (Ngugi  et  al.,  2013).  None  of  the
atients with  ACE  had  evidence  of  exposure  to  neurocys-
icercosis, an  established  risk  factor  for  epilepsy  in  other
arts of  Africa.  These  results  differ  markedly  from  the  East-
rn Cape  province  of  South  Africa,  where  an  estimated
4,662 cases  (95%  CI:  17,167—54,068)  of  epilepsy  related  to
eurocysticercosis occurred  in  2004  (Carabin  et  al.,  2006).
his difference  is  likely  the  result  of  very  little  free-range
ig farming  within  the  Agincourt  sub-district  and  regionally,
oupled with  some  local  religions  forbidding  consumption  of
ork.
uman immunodeﬁciency  virus  (HIV)
urprisingly,  we  did  not  ﬁnd  HIV  infection  to  be  a  risk
actor for  ACE,  even  though  the  prevalence  of  HIV  infec-
ion in  this  area  is  high  (18%  of  cases  and  23%  of  controls
n this  study)  (Gómez-Olivé  et  al.,  2013).  While  HIV  was
ot shown  to  be  a risk  factor  for  ACE,  studies  elsewhere
eport new-onset  seizures  to  be  associated  with  HIV  infec-
ion and  subsequent  opportunistic  infections  (Satishchandra
nd Sinha,  2008).  HIV  was  furthermore  not  associated  with
dult onset  epilepsy  nor  was  toxoplasmosis  associated  with
IV in  this  study.  Due  to  the  cross-sectional  design  of  this
tudy, individuals  at  risk  for  epilepsy,  because  of  an  oppor-
unistic infection  due  to  HIV,  may  be  missed  due  to  early
ortality. More  research  on  interactions  between  HIV  and
pilepsy is  indicated,  particularly  in  the  absence  of  oppor-
unistic cerebral  infections.
onclusion
his  study,  the  largest  population-based  epilepsy  study  in
ural South  Africa  to-date,  found  convulsive  epilepsy  to  be
ess frequent  in  this  area  than  in  other  parts  of  SSA,  with
igniﬁcant heterogeneity  between  villages.  The  lower  preva-
ence levels  of  epilepsy  found  in  this  study  could  be  due  to
he deﬁnition  of  epilepsy  used  in  this  study,  increased  access
o professional  support  during  birth  leading  to  reduced
dverse perinatal  events  or  lack  of  parasites.  More  than  half
f all  patients  had  the  onset  of  seizures  within  the  ﬁrst  two
ecades of  life  and  risk  factors  include  a  family  history  of
eizures, problems  during  delivery,  and  a  history  of  snoring.
IV was  not  found  to  be  a  risk  factor  for  developing  ACE.
iven the  substantial  burden  of  epilepsy,  further  research
n the  burden,  including  morbidity  and  mortality,  as  well  as
reatment options  for  and  economic  burden  of  epilepsy  in
ural SSA  is  warranted.onﬂicts of Interest
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